Skip to main content
logo
Simcere Pharmaceutical Group Limited (HKG:2096)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
11.52
+0.53 (4.82%)
Sep 2, 2026, 10:24 AM HKT

HKG:2096 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,344722714.76930.871,507
Depreciation & Amortization
380.82337.84291.51268.66234.39
Other Amortization
0.020.0218.0914.9917.42
Loss (Gain) From Sale of Assets
-0.231.5-791.9210.57-402.02
Asset Writedown & Restructuring Costs
--28.47--
Loss (Gain) From Sale of Investments
-137.08266.25744.82-113.11-697.19
Loss (Gain) on Equity Investments
1.11-2.16-7.84-0.1944.19
Stock-Based Compensation
89.5797.8112.12138.2962.39
Provision & Write-off of Bad Debts
-2.92-6.84-0.87-13.9715.83
Other Operating Activities
-103.6948.962.6838.36-182.36
Change in Accounts Receivable
-192.72-95.46-322.986.24-545.2
Change in Inventory
-42.69-24.53-376.64-116.99-8.33
Change in Accounts Payable
----81.87
Change in Unearned Revenue
72.385.57-10.24-14.26-30.34
Change in Other Net Operating Assets
604.9740.24-210.99124.65-299.73
Operating Cash Flow
2,0141,391151.051,354-201.97
Operating Cash Flow Growth
44.74%820.99%-88.84%--

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-349.33-369.98-483.18-342.82-209.49
Sale of Property, Plant & Equipment
0.7650.09118.310.275.91
Divestitures
-34.11993.52-97.7
Sale (Purchase) of Intangibles
-512.88-405.6-496.67-335.19-
Investment in Securities
-530.68-512.98793.29479.5-1,091
Other Investing Activities
61.45131.65162.54266.54761.71
Investing Cash Flow
-1,331-1,0731,08868.31-435.5

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
1,0521,2531,216916.931,027
Total Debt Issued
1,0521,2531,216916.931,027
Long-Term Debt Repaid
-1,132-1,505-1,367-1,233-2,505
Total Debt Repaid
-1,132-1,505-1,367-1,233-2,505
Net Debt Issued (Repaid)
-80.09-252.13-151.07-316.38-1,478
Issuance of Common Stock
1,42730.84---
Repurchase of Common Stock
-74.3-687.99-289.07--
Common Dividends Paid
-390.75-401.48-419.22-391.3-391.3
Other Financing Activities
12.45934.19-35.47-46.01244.75
Financing Cash Flow
894.39-376.56-894.83-753.68-1,625

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-17.742.294.8315.12-35.1
Net Cash Flow
1,560-55.85348.85683.85-2,297

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,6641,021-332.131,011-411.46
Free Cash Flow Growth
62.97%----
Free Cash Flow Margin
21.52%15.39%-5.03%15.99%-8.23%
Free Cash Flow Per Share
0.670.41-0.130.39-0.16
Levered Free Cash Flow
776.72429.35-1,045175.48438.89
Unlevered Free Cash Flow
836.6472.83-1,023196.99483.17

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
21.2630.7935.4729.9870.85
Cash Income Tax Paid
341.06114.5410.18-7.114.7
Change in Working Capital
441.94-74.18-920.7679.64-801.72